Management of Cardiovascular Disease in Kidney Disease (MaCK) Study

A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 100 participants.

Also called NCT03636152

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Phase 2
Enrolled
  • 100 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT03636152
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT03636152. Randomized; quadruple masking; primary purpose treatment. Start 2018-12-14 (actual); primary completion 2024-01-31 (actual). Results posted on 2026-08-20.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Management of Cardiovascular Disease in Kidney Disease (MaCK) Study
Acronym
MaCK
Condition
Cardiovascular Disease
Condition
Inflammation
Condition
Atherosclerosis
Condition
Aortic Stiffness
Intervention (Procedure)
MRI carotid
Intervention (Procedure)
APWV
Intervention (Drug)
Hydroxychloroquine
Intervention (Drug)
Matching Placebo
Lead sponsor
VA Office of Research and Development (class: US federal agency)

Record details

Record id
cardio:ct-nct03636152
Content hash
3ba921b38c8f081fc84be17895438095ec63f6020fc40606490604cbd1b581e8